Zur Kurzanzeige

2019-10-04Zeitschriftenartikel DOI: 10.25646/6617
Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry
dc.contributor.authorKraft, Magdalena
dc.contributor.authorKnop, Macarena Pia
dc.contributor.authorRenaudin, Jean-Marie
dc.contributor.authorScherer Hofmeier, Kathrin
dc.contributor.authorPföhler, Claudia
dc.contributor.authorBilò, Maria Beatrice
dc.contributor.authorLang, Roland
dc.contributor.authorTreudler, Regina
dc.contributor.authorWagner, Nicola
dc.contributor.authorSpindler, Thomas
dc.contributor.authorO'B Hourihane, Jonathan
dc.contributor.authorMaris, Ioana
dc.contributor.authorKoehli, Alice
dc.contributor.authorBauer, Andrea
dc.contributor.authorLange, Lars
dc.contributor.authorMüller, Sabine
dc.contributor.authorPapadopoulos, Nikolaos G.
dc.contributor.authorWedi, Bettina
dc.contributor.authorMoeser, Anne
dc.contributor.authorEnsina, Luis F.
dc.contributor.authorFernandez-Rivas, Montserrat
dc.contributor.authorCichocka-Jarosz, Ewa
dc.contributor.authorChristoff, George
dc.contributor.authorGarcia, Blanca E.
dc.contributor.authorPoziomkowska-Gęsicka, Iwona
dc.contributor.authorCardona, Victoria
dc.contributor.authorMustakov, Tihomir B.
dc.contributor.authorRabe, Uta
dc.contributor.authorMahler, Vera
dc.contributor.authorGrabenhenrich, Linus
dc.contributor.authorDölle-Bierke, Sabine
dc.contributor.authorWorm, Margitta
dc.contributor.authorThe Network for Online Registration of Anaphylaxis (NORA)
dc.date.accessioned2020-03-30T08:40:57Z
dc.date.available2020-03-30T08:40:57Z
dc.date.issued2019-10-04none
dc.identifier.other10.1111/all.14069
dc.identifier.urihttp://edoc.rki.de/176904/6577
dc.description.abstractBackground Patients with a history of anaphylaxis are at risk of future anaphylactic reactions. Thus, secondary prevention measures are recommended for these patients to prevent or attenuate the next reaction. Methods Data from the Anaphylaxis Registry were analyzed to identify secondary prevention measures offered to patients who experienced anaphylaxis. Our analysis included 7788 cases from 10 European countries and Brazil. Results The secondary prevention measures offered varied across the elicitors. A remarkable discrepancy was observed between prevention measures offered in specialized allergy centers (84% of patients were prescribed adrenaline autoinjectors following EAACI guidelines) and outside the centers: Here, EAACI guideline adherence was only 37%. In the multivariate analysis, the elicitor of the reaction, age of the patient, mastocytosis as comorbidity, severity of the reaction, and reimbursement/availability of the autoinjector influence physician's decision to prescribe one. Conclusions Based on the low implementation of guidelines concerning secondary prevention measures outside of specialized allergy centers, our findings highlight the importance of these specialized centers and the requirement of better education for primary healthcare and emergency physicians.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.rights(CC BY 3.0 DE) Namensnennung 3.0 Deutschlandger
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/de/
dc.subjectadrenaline autoinjectoreng
dc.subjectanaphylactic reactioneng
dc.subjectanaphylaxiseng
dc.subjectepinephrine autoinjectoreng
dc.subjectsecondary preventioneng
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleSecondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registrynone
dc.typearticle
dc.identifier.urnurn:nbn:de:kobv:0257-176904/6577-6
dc.identifier.doihttp://dx.doi.org/10.25646/6617
dc.type.versionpublishedVersionnone
local.edoc.container-titleAllergynone
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://onlinelibrary.wiley.com/doi/full/10.1111/all.14069none
local.edoc.container-publisher-nameWiley-Blackwellnone
local.edoc.container-volume2019none
local.edoc.container-issue00none
local.edoc.container-year2019none
local.edoc.container-firstpage1none
local.edoc.container-lastpage10none
local.edoc.rki-departmentInfektionsepidemiologienone
dc.description.versionPeer Reviewednone

Zur Kurzanzeige